CORVUS PHARMACEUTICALS INC's ticker is CRVS and the CUSIP is 221015100. A total of 53 filers reported holding CORVUS PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $88,000 | +10.0% | 21,909 | -0.0% | 0.00% | – |
| Q4 2018 | $80,000 | -79.4% | 21,913 | -51.6% | 0.00% | – |
| Q3 2018 | $388,000 | +26.4% | 45,290 | +62.2% | 0.00% | – |
| Q2 2018 | $307,000 | +14.6% | 27,924 | +20.0% | 0.00% | – |
| Q1 2018 | $268,000 | +11.2% | 23,275 | 0.0% | 0.00% | – |
| Q4 2017 | $241,000 | -36.9% | 23,275 | -2.8% | 0.00% | – |
| Q3 2017 | $382,000 | +35.0% | 23,948 | +2.5% | 0.00% | – |
| Q2 2017 | $283,000 | +89.9% | 23,354 | +225.2% | 0.00% | – |
| Q1 2017 | $149,000 | +106.9% | 7,181 | +43.3% | 0.00% | – |
| Q4 2016 | $72,000 | -4.0% | 5,011 | +9.3% | 0.00% | – |
| Q3 2016 | $75,000 | -69.8% | 4,583 | -73.6% | 0.00% | – |
| Q2 2016 | $248,000 | – | 17,361 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 3,749,379 | $18,147,000 | 3.77% |
| VR Adviser, LLC | 3,427,461 | $16,589,000 | 2.13% |
| ADAMS STREET PARTNERS LLC | 3,275,616 | $15,854,000 | 2.04% |
| Telemetry Investments, L.L.C. | 196,168 | $949,000 | 1.28% |
| DC Investments Management, LLC | 50,709 | $245,000 | 0.46% |
| Orbimed Advisors | 6,943,654 | $33,607,000 | 0.37% |
| EcoR1 Capital, LLC | 2,081,077 | $10,072,000 | 0.35% |
| BVF INC/IL | 1,370,947 | $6,635,000 | 0.26% |
| Ikarian Capital, LLC | 757,545 | $3,666,000 | 0.26% |
| CHI Advisors LLC | 165,927 | $803,000 | 0.23% |